Medicine, Pharma, Thought Leadership
Robin Farmanfarmaian
Med-tech Futurist, Investor, Entrepreneur, Author and Speaker
Robin Farmanfarmaian is a professional speaker and healthcare entrepreneur working with cutting-edge Artificial Intelligence Software, Device and Pharma companies poised to impact 100M+ patients.
Robin has had hands-on involvement with over 20 early-stage biotech and healthcare startups from curing cancer to medical devices and digital health. She also serves as strategic advisor to numerous companies, including Luxsonic Technologies who are working on a portable and modular radiology reading room in VR; Alacrity Care, a remote patient monitoring and data analytics solution for oncology; and ConceptVines, a VC fund and product engineering firm focused on disruptive tech.
Previously, she served as Vice President at Actavalon, an oncology-focused company focused on curing cancer, and as Strategic Relations Advisor to MindMaze, a company pioneering VR for stroke and brain injury rehabilitation. Her recent investments include Invicta Medical, a medical technology company addressing sleep apnea, and Dance Biopharm, focused on the development of inhaled insulin products to treat diabetes patients worldwide.
Robin is the author of 4 books, with her first in 2015, “The Patient as CEO: How Technology Empowers the Healthcare Consumer”, becoming an Amazon Best Seller. She subsequently published "The Thought Leader Formula: Strategically Leverage Your Expertise to Drive Business & Career Goals" (2019) and in 2020 during the global pandemic, "Facilitating Virtual Events: Driving Participant Engagement & Interaction" (2020). Her 4th book, "How AI Can Democratize Healthcare" with Michael Ferro, was published in September ’22.
Robin has delivered more than 180 keynotes in 15 countries, educating audiences on technology intersecting with healthcare, including artificial intelligence and the shift in healthcare delivery to the patient’s home.
More Advisory Board
Robin Farmanfarmaian is a professional speaker and healthcare entrepreneur working with cutting-edge Artificial Intelligence Software, Device and Pharma companies poised to impact 100M+ patients.
Robin has had hands-on involvement with over 20 early-stage biotech and healthcare startups from curing cancer to medical devices and digital health. She also serves as strategic advisor to numerous companies, including Luxsonic Technologies who are working on a portable and modular radiology reading room in VR; Alacrity Care, a remote patient monitoring and data analytics solution for oncology; and ConceptVines, a VC fund and product engineering firm focused on disruptive tech.
Previously, she served as Vice President at Actavalon, an oncology-focused company focused on curing cancer, and as Strategic Relations Advisor to MindMaze, a company pioneering VR for stroke and brain injury rehabilitation. Her recent investments include Invicta Medical, a medical technology company addressing sleep apnea, and Dance Biopharm, focused on the development of inhaled insulin products to treat diabetes patients worldwide.
Robin is the author of 4 books, with her first in 2015, “The Patient as CEO: How Technology Empowers the Healthcare Consumer”, becoming an Amazon Best Seller. She subsequently published "The Thought Leader Formula: Strategically Leverage Your Expertise to Drive Business & Career Goals" (2019) and in 2020 during the global pandemic, "Facilitating Virtual Events: Driving Participant Engagement & Interaction" (2020). Her 4th book, "How AI Can Democratize Healthcare" with Michael Ferro, was published in September ’22.
Robin has delivered more than 180 keynotes in 15 countries, educating audiences on technology intersecting with healthcare, including artificial intelligence and the shift in healthcare delivery to the patient’s home.
